Antioxidants inhibit neuronal toxicity in Parkinson's disease-linked LRRK2
about
Targeting LRRK2 in Parkinson's disease: an update on recent developments.Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity.Therapeutic Versatility of Resveratrol Derivatives.Parkinson disease: Insect screens for PD therapies - keep the flies in.
P2860
Antioxidants inhibit neuronal toxicity in Parkinson's disease-linked LRRK2
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Antioxidants inhibit neuronal toxicity in Parkinson's disease-linked LRRK2
@ast
Antioxidants inhibit neuronal toxicity in Parkinson's disease-linked LRRK2
@en
type
label
Antioxidants inhibit neuronal toxicity in Parkinson's disease-linked LRRK2
@ast
Antioxidants inhibit neuronal toxicity in Parkinson's disease-linked LRRK2
@en
prefLabel
Antioxidants inhibit neuronal toxicity in Parkinson's disease-linked LRRK2
@ast
Antioxidants inhibit neuronal toxicity in Parkinson's disease-linked LRRK2
@en
P2093
P2860
P356
P1476
Antioxidants inhibit neuronal toxicity in Parkinson's disease-linked LRRK2
@en
P2093
Brian W Dymock
Dario C Angeles
Kah-Leong Lim
Patrick Ho
Zhi-Dong Zhou
P2860
P304
P356
10.1002/ACN3.282
P50
P577
2016-03-02T00:00:00Z